Drug · DIN 02458454
EMERADE
SINGLE-USE PREFILLED PEN
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since March 16, 2026; first marketed October 8, 2020.
- Drug Identification Number (DIN)
- 02458454
- Company (DIN owner)
- Bausch Health, Canada Inc.Laval, Quebec, Canada
- Schedule
- Ethical
- Dosage form
- Solution
- Route
- Intramuscular
- Therapeutic class (ATC)
- Epinephrine C01CA24
- Class
- Human
- Record last updated
- August 10, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| EPINEPHRINE (EPINEPHRINE BITARTRATE) | 0.5 MG | 0.5 ML |
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “emerade”. A notice may cover another product or only some lots: read it to see what it covers.
- Emerade injection; Device failureMay 8, 2023 · Drugs · Product quality · Type I
- Bausch Health, Canada Inc. recalls all lots of Emerade epinephrine auto-injectors (0.3 mg and 0.5 mg strengths) due to possible device failureMay 5, 2023 · Health products · Other
Other DINs named EMERADE
- DIN 02458438 · Cancelled Pre Market
- DIN 02458446 · Cancelled Post Market